- About Us
- Research Team
Qatar Biomedical Research Institute (QBRI) is a pioneering national research institute within Hamad bin Khalifa University (HBKU) that aims to improve and transform healthcare through innovation in prevention, diagnosis, and treatment of diseases affecting the Qatari population and the region.
We are at the forefront of the development of advanced national facilities, cutting-edge technologies, and enabling platforms as new scientific discoveries are translated into better therapies and strategies, to combat diseases. As a disease-focused institute we concentrate on applying integrative and multidisciplinary approaches to provide novel insights into the molecular basis of the health challenges of breast cancer; type 2 diabetes; neurological disorders such as dementia and autism; and the development of novel biomarkers, diagnostic and therapeutic strategies. Our aim is to facilitate early diagnosis, treatment, and management of these devastating diseases towards improving personalized medicine and healthcare.
In keeping with Qatar National Health priorities and Qatar National Research Strategy, we operate three scientific centers of excellence:
Our flexible structure allows us to respond to the rapidly changing medical, biomedical, and health needs of Qatari society and industry. This enables rapid adjustment to new scientific and technological advances, which in turn empowers us to remain at the forefront of biomedical research.
We are committed to the training and development of the next generation of scientists and highly skilled workers by providing mentoring, advanced scientific and research training opportunities, and career guidance to young scientists.
QBRI is currently looking to recruit highly-skilled individuals for a number of roles.
Adamcik J, Sánchez-Ferrer A, Ait-Bouziad N, Reynolds NP, Lashuel HA*, Mezzenga R. (2015). Microtubule-Binding R3 Fragment from Tau Self-Assembles into Giant Multistranded Amyloid Ribbons. Angew Chem Int Ed Engl. 11;55(2):618-22.
Vasiliki P Chini (2015). Micro-RNAs and Next Generation Sequencing: New Perspectives in Heart Failure. Clin Chim Acta, Mar 30; 443:114-9.
Kolatkar PR, Moovarkumudalvan B, Abdelalim EM and Emara MM. (2016). Three dimensional Structure of SOX Protein–DNA Complexes. Sox2: Biology and Role in Development and Disease. 2016 ELSEVIER. P 15-24.
Balbekova A, Lohninger H, van Tilborg GAF, Dijkhuizen RM, Bonta M, Limbeck A, Lendl B, Al-Saad KA, Ali M, Celikic M, Ofner J. (2017). Fourier Transform Infrared (FT-IR) and Laser Ablation Inductively Coupled Plasma–Mass Spectrometry (LA-ICP-MS) Imaging of Cerebral Ischemia: Combined Analysis of Rat Brain Thin Cuts Toward Improved Tissue Classification. Appl Spectrosc. 2018 Feb;72(2):241-250. doi: 10.1177/0003702817734618.
Abdelalim EM and Emara MM. (2017). Pluripotent stem cell-derived pancreatic beta cells: from In vitro maturation to clinical applications. Recent Advances in Stem Cells: From Basic Research to Clinical Applications, ISBN 978-319-33270-3, pp 101-129, Springer.
As part of its extensive, month-long Autism Awareness Campaign, QBRI participated in various events across Doha, to shed light on the importance of early detection of autism spectrum disorder (ASD) ...
Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease
The Qatar Metabolic Institute is very pleased to present the 1st Annual Qatar Metabolic Institute Conference. The conference, co-organized by Hamad Medical Corporation (HMC) and Qatar Biomedical ...
Qatar Foundation Research and Development’s flagship conference, builds upon nationwide efforts to advance Qatar's ambitious research agenda, and provides a unique platform to activate ...